Results 31 to 40 of about 93,945 (299)
The progress that has been made in the treatment of rectal cancer has mostly resulted from multimodality strategy approach that combines surgery, chemotherapy and radiotherapy.
Nikolić, Aleksandra, Krivokapić, Zoran
core +1 more source
Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen +19 more
wiley +1 more source
Gene and microRNA expression predictive of tumour response in patients treated with preoperative chemoradiotherapy for rectal cancer [PDF]
Background Preoperative chemoradiotherapy (pCRT) followed by surgery is the standard treatment for locally advanced rectal cancer (LARC). However, the response to pCRT is not uniform, and there is no effective method to predict tumour response to pCRT ...
Maretto, I
core
Sequential Evaluation of Swallowing Function During Chemoradiotherapy for Head and Neck Cancer [PDF]
[Background] Many studies have addressed chronic dysphagia resulting from chemoradiotherapy for head and neck cancer (HNC) because of its severity, but changes in the swallowing function during chemoradiotherapy has been rarely reported. This study aimed
Fukuhara, Takahiro +14 more
core +1 more source
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho +4 more
wiley +1 more source
The 3-year follow-up of the phase 3 RATIONALE-309 trial confirmed sustained progression-free and overall survival (OS) benefit with tislelizumab plus gemcitabine-cisplatin in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).
Qing-Hua Ke, Shi-Qiong Zhou
doaj +1 more source
Chemoradiotherapy in pancreatic carcinoma
AbstractPancreatic cancer patients present late in their course and surgical resection as a modality of treatment is of limited value. Majority develop loco-regional failure and distant metastasis, therefore, adjuvant therapy comprising of radiotherapy and chemotherapy are useful treatment options to achieve higher loco-regional control.
Pathy Sushmita, Chander Subhash
openaire +4 more sources
Background: Breast cancer stem cells (BCSCs) are instrumental in treatment resistance, recurrence, and metastasis. The development of breast cancer and radiation sensitivity is intimately pertinent to long non-coding RNA (lncRNA). This
Yunbao Xu +3 more
doaj +1 more source
The study establishes an immune‐cure (ICu) mouse model based on a TMEMed G422TN‐GBM system that faithfully recapitulates human TMEMed GBM. scRNA‐seq analysis reveals a Csmd3+ microglial subset with innate immune memory (IIM) potential that potently suppresses GBM growth, drives a TME cold‐to‐hot transition, and induces 100% ICu in long‐term survival ...
Hai‐Feng Jiang +12 more
wiley +1 more source
Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer [PDF]
Aim: Pancreatic cancer (PC) is one of the most aggressive cancers, with a 5-year survival rate of less than 50% in resectable stages. The aim of this study was to determine the survival effect of adjuvant chemoradiotherapy (CRT) in resected PC ...
Yakup İRİAĞAÇ +5 more
core +1 more source

